Skip to content

J-pouch Versus Side-to-end Coloanal Anastomosis After Preoperative Radiotherapy and Total Mesorectal Excision for Rectal Cancer

J-pouch Versus Side-to-end Coloanal Anastomosis After Preoperative Radiotherapy and Total Mesorectal Excision for Rectal Cancer: a Multicenter Randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00956241
Enrollment
127
Registered
2009-08-11
Start date
2002-04-30
Completion date
2007-01-31
Last updated
2009-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Cancer

Keywords

rectal cancer, colonic pouch, side-to-end anastomosis, preoperative radiotherapy

Brief summary

The objective of this study was to compare the functional and surgical results of the J-pouch with those of the side-to-end anastomosis and their impact on quality of life.

Detailed description

Invalidating anorectal dysfunctions are common after restorative rectal surgery. Improvement of functional results by the technically more demanding J-pouch has been demonstrated in comparison with the straight coloanal anastomosis. In the present multicenter randomized trial we assessed whether the J-pouch is also superior to the side-to-end coloanal anastomosis.

Interventions

PROCEDUREj-pouch coloanal anastomosis
PROCEDUREside-to-end coloanal anastomosis

Sponsors

Dutch Digestive Diseases Foundation
CollaboratorOTHER
Commission of Applied Clinical Research (Commissie voor Klinisch Toegepast Onderzoek: CKTO).
CollaboratorUNKNOWN
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* The inclusion criteria comprised a histologically proven rectal cancer located in the middle or distal part of the rectum (≤ 10cm from the anal verge), and a WHO performance status ≤ 2.

Exclusion criteria

* Patients with a T1 or T4 tumor were excluded * Patients diagnosed with distant metastases * A medical history of colonic resection * Anorectal surgery or chemo- radiotherapy * Pre-existing fecal incontinence grade III or IV according to Parks10 * Life expectancy of less than one year.

Design outcomes

Primary

MeasureTime frame
Primary endpoint was the function of the neo-rectum as assessed by a validated functional outcome questionnaire at 4 months.4 months

Secondary

MeasureTime frame
Function of the neo-rectum as assessed by the functional outcome questionnaire12 months
Surgical results4 and 12 months
Quality of life4 and 12 months

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026